scholarly article | Q13442814 |
P356 | DOI | 10.1007/S12017-018-8507-9 |
P698 | PubMed publication ID | 30182330 |
P50 | author | Chunzhi Zhang | Q91291964 |
P2093 | author name string | Sai Liang | |
Wanli Yu | |||
P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 | Q24322196 | ||
MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators | Q24336898 | ||
Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism | Q24600173 | ||
miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression | Q24610377 | ||
An extensive microRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma | Q24629145 | ||
The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website | Q24645514 | ||
IDH1 and IDH2 mutations in gliomas | Q24648948 | ||
miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells | Q24649056 | ||
Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1 | Q24651548 | ||
Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model | Q24655262 | ||
Comprehensive genomic characterization defines human glioblastoma genes and core pathways | Q24656128 | ||
The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 | ||
Deletion of RDINK4/ARF enhancer: A novel mutation to "inactivate" the INK4-ARF locus | Q39422458 | ||
MicroRNA-7 regulates glioblastoma cell invasion via targeting focal adhesion kinase expression | Q39450296 | ||
Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme | Q39606772 | ||
Over-expression of miR-100 is responsible for the low-expression of ATM in the human glioma cell line: M059J | Q39651756 | ||
Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status | Q39756064 | ||
Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell-derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity | Q39776996 | ||
Macrophage Migration Inhibitory Factor (MIF) Supports Homing of Osteoclast Precursors to Peripheral Osteolytic Lesions | Q39848278 | ||
MicroRNA-138 promotes acquired alkylator resistance in glioblastoma by targeting the Bcl-2-interacting mediator BIM. | Q39990148 | ||
Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest | Q39992760 | ||
Regulation of GLUT3 and glucose uptake by the cAMP signalling pathway in the breast cancer cell line ZR-75. | Q40122040 | ||
Contribution of Notch signaling activation to human glioblastoma multiforme. | Q40157837 | ||
Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth. | Q40179252 | ||
TGF-beta and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells | Q40246842 | ||
Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma | Q40291239 | ||
MiR-429 induces apoptosis of glioblastoma cell through Bcl-2. | Q40381720 | ||
MiR-126 Regulates the ERK Pathway via Targeting KRAS to Inhibit the Glioma Cell Proliferation and Invasion | Q40999025 | ||
MicroRNA‑141 inhibits the self‑renewal of glioblastoma stem cells via Jagged1 | Q41059804 | ||
SDF1-CXCR4 Signaling Maintains Central Post-Stroke Pain through Mediation of Glial-Neuronal Interactions | Q41074630 | ||
TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells | Q41164260 | ||
A Short Region of Connexin43 Reduces Human Glioma Stem Cell Migration, Invasion, and Survival through Src, PTEN, and FAK. | Q41325859 | ||
miR-133a Promotes TRAIL Resistance in Glioblastoma via Suppressing Death Receptor 5 and Activating NF-κB Signaling. | Q41440890 | ||
Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system | Q41483751 | ||
Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase | Q41639273 | ||
MicroRNA-132 induces temozolomide resistance and promotes the formation of cancer stem cell phenotypes by targeting tumor suppressor candidate 3 in glioblastoma | Q41846503 | ||
MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1. | Q42123071 | ||
Modulation of chemoresponsiveness to platinum-based agents by microRNAs in cancer | Q42215256 | ||
Interleukin-6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy | Q42288627 | ||
Serum microRNA profiling in patients with glioblastoma: a survival analysis | Q42317085 | ||
Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes | Q42371249 | ||
TRPA1-FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3p | Q42378963 | ||
MiR-31 promotes mammary stem cell expansion and breast tumorigenesis by suppressing Wnt signaling antagonists | Q42380563 | ||
MiR224-3p inhibits hypoxia-induced autophagy by targeting autophagy-related genes in human glioblastoma cells | Q36561540 | ||
MicroRNA-205 functions as a tumor suppressor in human glioblastoma cells by targeting VEGF-A | Q36642299 | ||
The Cancer Genome Atlas Analysis Predicts MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma. | Q36756817 | ||
MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints | Q36785139 | ||
Apoptosis signaling pathways and lymphocyte homeostasis | Q36852224 | ||
MiR-215 Is Induced Post-transcriptionally via HIF-Drosha Complex and Mediates Glioma-Initiating Cell Adaptation to Hypoxia by Targeting KDM1B. | Q36914209 | ||
At the bench: preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy | Q36935749 | ||
Epigenetic regulation of miRNA-211 by MMP-9 governs glioma cell apoptosis, chemosensitivity and radiosensitivity | Q37030916 | ||
Slits and Roundabouts in cancer, tumour angiogenesis and endothelial cell migration | Q37081036 | ||
PKM2 dephosphorylation by Cdc25A promotes the Warburg effect and tumorigenesis | Q37157031 | ||
MiR-145 functions as a tumor-suppressive RNA by targeting Sox9 and adducin 3 in human glioma cells | Q37187706 | ||
miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma | Q37191655 | ||
Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells | Q37221453 | ||
Up-regulation of miR-370-3p restores glioblastoma multiforme sensitivity to temozolomide by influencing MGMT expression | Q37232935 | ||
MicroRNA 203 Modulates Glioma Cell Migration via Robo1/ERK/MMP-9 Signaling. | Q37253571 | ||
Overexpressed let-7a inhibits glioma cell malignancy by directly targeting K-ras, independently of PTEN | Q37268874 | ||
miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastoma | Q37475020 | ||
Bax/Bak activation in the absence of Bid, Bim, Puma, and p53. | Q37482805 | ||
The prognostic value of a seven-microRNA classifier as a novel biomarker for the prediction and detection of recurrence in glioma patients | Q37619766 | ||
MicroRNA-564 is downregulated in glioblastoma and inhibited proliferation and invasion of glioblastoma cells by targeting TGF-β1. | Q37636608 | ||
Knockdown of NEAT1 restrained the malignant progression of glioma stem cells by activating microRNA let-7e | Q37641753 | ||
Epigenetic Activation of WNT5A Drives Glioblastoma Stem Cell Differentiation and Invasive Growth | Q37658825 | ||
MicroRNA-101 reverses temozolomide resistance by inhibition of GSK3β in glioblastoma | Q37694818 | ||
Autoreactive natural killer T cells: promoting immune protection and immune tolerance through varied interactions with myeloid antigen-presenting cells | Q37750917 | ||
Regulatory T cells in tumor immunity | Q37762224 | ||
TGF-beta1 interactome: metastasis and beyond. | Q37775435 | ||
Biomarkers downstream of RAS: a search for robust transcriptional targets | Q37780776 | ||
Targeting metabolic remodeling in glioblastoma multiforme | Q37840941 | ||
Evolutionary functional analysis and molecular regulation of the ZEB transcription factors | Q37986328 | ||
Ubiquitination in signaling to and activation of IKK. | Q37995681 | ||
The molecular profile of microglia under the influence of glioma | Q38008966 | ||
Cytokine stimulation of epithelial cancer cells: the similar and divergent functions of IL-4 and IL-13. | Q38065873 | ||
Detection methods for microRNAs in clinic practice | Q38090212 | ||
Cell transfer therapy for cancer: past, present, and future | Q38205228 | ||
Glioma Stem Cells: Signaling, Microenvironment, and Therapy | Q26765854 | ||
Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies | Q26823118 | ||
Adeno-associated virus-mediated microRNA delivery and therapeutics | Q27005597 | ||
MGMT gene silencing and benefit from temozolomide in glioblastoma | Q27824832 | ||
Epithelial-mesenchymal transitions in tumour progression | Q27860487 | ||
Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation | Q28140810 | ||
Identification of CDK4 sequences involved in cyclin D1 and p16 binding | Q28244094 | ||
Extensive modulation of a set of microRNAs in primary glioblastoma | Q28263314 | ||
TGFβ signalling in context | Q28275410 | ||
microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma | Q28280337 | ||
MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3 | Q28564217 | ||
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis | Q29547178 | ||
Hypoxia--a key regulatory factor in tumour growth | Q29547318 | ||
New functions for the matrix metalloproteinases in cancer progression | Q29547738 | ||
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis | Q29619677 | ||
Inflammation meets cancer, with NF-κB as the matchmaker | Q29620242 | ||
microRNA-148a is a prognostic oncomiR that targets MIG6 and BIM to regulate EGFR and apoptosis in glioblastoma | Q30407637 | ||
Novel anti-apoptotic microRNAs 582-5p and 363 promote human glioblastoma stem cell survival via direct inhibition of caspase 3, caspase 9, and Bim. | Q30413140 | ||
miR-219-5p inhibits receptor tyrosine kinase pathway by targeting EGFR in glioblastoma | Q30419258 | ||
Pyruvate kinase M2 is a target of the tumor-suppressive microRNA-326 and regulates the survival of glioma cells | Q30430077 | ||
MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes | Q30434616 | ||
microRNA regulatory network inference identifies miR-34a as a novel regulator of TGF-β signaling in glioblastoma. | Q30570563 | ||
Recent developments in the use of chemotherapy in brain tumours. | Q33232219 | ||
Overexpression of miR-29a reduces the oncogenic properties of glioblastoma stem cells by downregulating Quaking gene isoform 6 | Q33648713 | ||
Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship | Q33719798 | ||
At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy | Q33732329 | ||
Tumor suppressive miRNA-34a suppresses cell proliferation and tumor growth of glioma stem cells by targeting Akt and Wnt signaling pathways | Q33764768 | ||
Cross-talk between miRNA and Notch signaling pathways in tumor development and progression | Q33801752 | ||
Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential | Q33825657 | ||
Comparative profiling of primary colorectal carcinomas and liver metastases identifies LEF1 as a prognostic biomarker | Q33839507 | ||
Intratumoral Lentivector-Mediated TGF-β1 Gene Downregulation As a Potent Strategy for Enhancing the Antitumor Effect of Therapy Composed of Cyclophosphamide and Dendritic Cells | Q33858506 | ||
A ten-microRNA expression signature predicts survival in glioblastoma | Q33869822 | ||
NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts | Q33883897 | ||
14-3-3 binding sites in the snail protein are essential for snail-mediated transcriptional repression and epithelial-mesenchymal differentiation | Q33951080 | ||
Tailoring to RB: tumour suppressor status and therapeutic response | Q34040108 | ||
MicroRNA-1908 functions as a glioblastoma oncogene by suppressing PTEN tumor suppressor pathway | Q35945582 | ||
PKM2 promotes glucose metabolism and cell growth in gliomas through a mechanism involving a let-7a/c-Myc/hnRNPA1 feedback loop | Q35955191 | ||
miR-30e Blocks Autophagy and Acts Synergistically with Proanthocyanidin for Inhibition of AVEN and BIRC6 to Increase Apoptosis in Glioblastoma Stem Cells and Glioblastoma SNB19 Cells | Q36070278 | ||
VHL regulates the effects of miR-23b on glioma survival and invasion via suppression of HIF-1α/VEGF and β-catenin/Tcf-4 signaling | Q36127410 | ||
MicroRNA-542-3p Suppresses Tumor Cell Invasion via Targeting AKT Pathway in Human Astrocytoma | Q36139783 | ||
miR-29b attenuates tumorigenicity and stemness maintenance in human glioblastoma multiforme by directly targeting BCL2L2 | Q36210894 | ||
Loss of tumor suppressive microRNA-31 enhances TRADD/NF-κB signaling in glioblastoma | Q36232178 | ||
TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors | Q36235100 | ||
MicroRNA-199a-3p suppresses glioma cell proliferation by regulating the AKT/mTOR signaling pathway | Q36278102 | ||
cAMP response element-binding protein promotes gliomagenesis by modulating the expression of oncogenic microRNA-23a | Q36300857 | ||
MicroRNA-10b pleiotropically regulates invasion, angiogenicity and apoptosis of tumor cells resembling mesenchymal subtype of glioblastoma multiforme | Q36347204 | ||
Heterogeneity and plasticity of T helper cells | Q36388771 | ||
Matrix metalloproteinases: changing roles in tumor progression and metastasis | Q36422976 | ||
Neurotensin signaling stimulates glioblastoma cell proliferation by upregulating c-Myc and inhibiting miR-29b-1 and miR-129-3p | Q36493809 | ||
NOTCH signaling as a novel cancer therapeutic target | Q36539533 | ||
miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas | Q36557234 | ||
P70S6K 1 regulation of angiogenesis through VEGF and HIF-1alpha expression | Q34083360 | ||
MiR-181b sensitizes glioma cells to teniposide by targeting MDM2. | Q34136136 | ||
Chromatin-modifying drugs induce miRNA-153 expression to suppress Irs-2 in glioblastoma cell lines | Q34157966 | ||
Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases. | Q34159409 | ||
MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras | Q34193764 | ||
Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiforme | Q34207182 | ||
MiR-143 acts as a tumor suppressor by targeting N-RAS and enhances temozolomide-induced apoptosis in glioma | Q34221882 | ||
MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme | Q34262423 | ||
TGFβ in T cell biology and tumor immunity: Angel or devil? | Q34276027 | ||
MicroRNA-mediated down-regulation of NKG2D ligands contributes to glioma immune escape | Q34365811 | ||
Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma | Q34381578 | ||
A genome-wide miRNA screen revealed miR-603 as a MGMT-regulating miRNA in glioblastomas | Q34427825 | ||
Tumor antigen-specific T helper cells in cancer immunity and immunotherapy | Q34433202 | ||
The CREB-miR-9 negative feedback minicircuitry coordinates the migration and proliferation of glioma cells | Q34490171 | ||
MicroRNA-195 inhibits the proliferation of human glioma cells by directly targeting cyclin D1 and cyclin E1. | Q34575813 | ||
Activation of glioma cells generates immune tolerant NKT cells | Q34683179 | ||
Glioma cancer stem cells induce immunosuppressive macrophages/microglia | Q34992518 | ||
Downregulations of B-cell lymphoma 2 and myeloid cell leukemia sequence 1 by microRNA 153 induce apoptosis in a glioblastoma cell line DBTRG-05MG. | Q34997130 | ||
Decreased miR-106a inhibits glioma cell glucose uptake and proliferation by targeting SLC2A3 in GBM. | Q35017237 | ||
MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-κB1/MMP9 signaling pathway | Q35051948 | ||
Transgene-derived overexpression of miR-17-92 in CD8+ T-cells confers enhanced cytotoxic activity | Q35163556 | ||
miR-135b contributes to the radioresistance by targeting GSK3β in human glioblastoma multiforme cells | Q35284695 | ||
miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma | Q35293772 | ||
14-3-3 Proteins: diverse functions in cell proliferation and cancer progression | Q35566220 | ||
Deregulation of Snai2 is associated with metastasis and poor prognosis in tongue squamous cell carcinoma | Q35624074 | ||
Sumoylation of vimentin354 is associated with PIAS3 inhibition of glioma cell migration | Q35640113 | ||
A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy | Q35677134 | ||
HIF-1α is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway | Q35687115 | ||
miR-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma Cells | Q35770894 | ||
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors | Q35811255 | ||
MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2 | Q35832262 | ||
MiR-128 inhibits tumor growth and angiogenesis by targeting p70S6K1. | Q35839826 | ||
VSIG4 is highly expressed and correlated with poor prognosis of high-grade glioma patients | Q35941343 | ||
LGR5 regulates pro-survival MEK/ERK and proliferative Wnt/β-catenin signalling in neuroblastoma | Q38261762 | ||
Profiling estrogen-regulated gene expression changes in normal and malignant human ovarian surface epithelial cells. | Q38321797 | ||
TAp63alpha induces apoptosis by activating signaling via death receptors and mitochondria | Q38325201 | ||
MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10. | Q38336556 | ||
MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC. | Q38353056 | ||
miR-19a and miR-19b overexpression in gliomas | Q38395794 | ||
MiR-198 enhances temozolomide sensitivity in glioblastoma by targeting MGMT. | Q38692922 | ||
m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program | Q38710467 | ||
MiR-217 promoted the proliferation and invasion of glioblastoma by repressing YWHAG. | Q38719284 | ||
Effects of CDKN2A (p16INK4A/p14ARF) Over-Expression on Proliferation and Migration of Human Melanoma A375 Cells | Q38725224 | ||
Capn4 promotes epithelial-mesenchymal transition in human melanoma cells through activation of the Wnt/β-catenin pathway | Q38729493 | ||
Tissue mechanics promote IDH1-dependent HIF1α-tenascin C feedback to regulate glioblastoma aggression | Q38732546 | ||
Let-7g-5p inhibits epithelial-mesenchymal transition consistent with reduction of glioma stem cell phenotypes by targeting VSIG4 in glioblastoma | Q38737828 | ||
The renewed battle against RAS-mutant cancers | Q38740000 | ||
Immunotherapy and radiation in glioblastoma. | Q38752191 | ||
MicroRNA-34a inhibits cell proliferation and induces cell apoptosis of glioma cells via targeting of Bcl-2. | Q38771273 | ||
MiR-181b modulates chemosensitivity of glioblastoma multiforme cells to temozolomide by targeting the epidermal growth factor receptor | Q38787480 | ||
MiR-608 inhibits the migration and invasion of glioma stem cells by targeting macrophage migration inhibitory factor | Q38789492 | ||
miR-373 Inhibits Glioma Cell U251 Migration and Invasion by Down-Regulating CD44 and TGFBR2. | Q38795514 | ||
MicroRNA-663 inhibits the proliferation, migration and invasion of glioblastoma cells via targeting TGF-β1. | Q38807949 | ||
MicroRNA-181c inhibits glioblastoma cell invasion, migration and mesenchymal transition by targeting TGF-β pathway | Q38810687 | ||
Upregulated miRNA-622 inhibited cell proliferation, motility, and invasion via repressing Kirsten rat sarcoma in glioblastoma | Q38817536 | ||
MicroRNA‑566 modulates vascular endothelial growth factor by targeting Von Hippel‑Landau in human glioblastoma in vitro and in vivo | Q38819321 | ||
miR-590-3p suppresses cancer cell migration, invasion and epithelial-mesenchymal transition in glioblastoma multiforme by targeting ZEB1 and ZEB2. | Q38820350 | ||
miR-124 suppresses the migration and invasion of glioma cells in vitro via Capn4. | Q38822348 | ||
MicroRNA-129-1 acts as tumour suppressor and induces cell cycle arrest of GBM cancer cells through targeting IGF2BP3 and MAPK1. | Q38824154 | ||
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary | Q38829244 | ||
miR-144-3p exerts anti-tumor effects in glioblastoma by targeting c-Met | Q38845681 | ||
Upregulation of miR-181a suppresses the formation of glioblastoma stem cells by targeting the Notch2 oncogene and correlates with good prognosis in patients with glioblastoma multiforme | Q38847371 | ||
Presentation of Two Cases with Early Extracranial Metastases from Glioblastoma and Review of the Literature. | Q38849886 | ||
Growth of glioblastoma is inhibited by miR-133-mediated EGFR suppression | Q38857175 | ||
miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma | Q38869719 | ||
miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression | Q38876901 | ||
Doxycycline inhibits leukemic cell migration via inhibition of matrix metalloproteinases and phosphorylation of focal adhesion kinase | Q42419112 | ||
TGF-beta downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients | Q42426054 | ||
Canonical NFκB signaling in myeloid cells is required for the glioblastoma growth | Q42645448 | ||
New prospects on the NKG2D/NKG2DL system for oncology | Q42796257 | ||
Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. | Q43283510 | ||
Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline | Q43580249 | ||
Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin | Q44209275 | ||
MiR-26a enhances the radiosensitivity of glioblastoma multiforme cells through targeting of ataxia-telangiectasia mutated | Q45012413 | ||
miR-125b inhibitor enhance the chemosensitivity of glioblastoma stem cells to temozolomide by targeting Bak1. | Q45044001 | ||
Radiation Therapy for Glioblastoma: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Guideline | Q45270171 | ||
Anti-cancer effect of R3V6 peptide-mediated delivery of an anti-microRNA-21 antisense-oligodeoxynucleotide in a glioblastoma animal model | Q45855761 | ||
Glucose metabolites, glutamate and glycerol in malignant glioma tumours during radiotherapy | Q46532765 | ||
A Selective Cyclin-Dependent Kinase 4, 6 Dual Inhibitor, Ribociclib (LEE011) Inhibits Cell Proliferation and Induces Apoptosis in Aggressive Thyroid Cancer. | Q47202838 | ||
Inhibition of cancer cell migration with CuS@ mSiO2-PEG nanoparticles by repressing MMP-2/MMP-9 expression | Q47215416 | ||
Expression of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancer | Q47345855 | ||
Krüppel Like Factors Family Expression in Cervical Cancer Cells | Q47382515 | ||
Prognostic relevance of genetic alterations in diffuse lower-grade gliomas | Q47583690 | ||
Macrophage migration inhibitory factor promotes vasculogenic mimicry formation induced by hypoxia via CXCR4/AKT/EMT pathway in human glioblastoma cells | Q47638547 | ||
Exosomes from Glioma-Associated Mesenchymal Stem Cells Increase the Tumorigenicity of Glioma Stem-like Cells via Transfer of miR-1587. | Q47881690 | ||
Mesenchymal Stem Cells as Natural Bio-Factories for Exosomes Carrying miR-124a in the Treatment of Gliomas | Q48025819 | ||
Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy. | Q48134470 | ||
Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells | Q48135067 | ||
Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines | Q48154511 | ||
Macrophage migration inhibitory factor mediates viability and apoptosis of PVM/Ms through PI3K/Akt pathway | Q48202458 | ||
MicroRNA-520c inhibits glioma cell migration and invasion by the suppression of transforming growth factor-β receptor type 2. | Q48315466 | ||
MiR-152 functions as a tumor suppressor in glioblastoma stem cells by targeting Krüppel-like factor 4. | Q48545857 | ||
Radiogenomics to characterize regional genetic heterogeneity in glioblastoma | Q48582092 | ||
Myc-associated zinc finger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma | Q48616366 | ||
Immunocytochemical analysis of glomerular regionalization and neuronal diversity in the olfactory deutocerebrum of the spiny lobster | Q48797706 | ||
Aging and the Krüppel-like factors | Q49372792 | ||
The Wnt Transcriptional Switch: TLE Removal or Inactivation? | Q49693008 | ||
HMG-box transcription factor 1: a positive regulator of the G1/S transition through the Cyclin-CDK-CDKI molecular network in nasopharyngeal carcinoma | Q49724235 | ||
PTEN/PTENP1: 'Regulating the regulator of RTK-dependent PI3K/Akt signalling', new targets for cancer therapy. | Q49887901 | ||
Receptor tyrosine kinases and downstream pathways as druggable targets for cancer treatment: the current arsenal of inhibitors | Q49887919 | ||
Mitochondrial MDM2 Regulates Respiratory Complex I Activity Independently of p53. | Q49920435 | ||
Ezh2 promotes clock function and hematopoiesis independent of histone methyltransferase activity in zebrafish | Q49977670 | ||
A 4-miRNAs signature predicts survival in glioblastoma multiforme patients. | Q50225594 | ||
Metformin inhibits TGF-β1-induced epithelial-to-mesenchymal transition-like process and stem-like properties in GBM via AKT/mTOR/ZEB1 pathway. | Q50327413 | ||
MiR-181b modulates EGFR-dependent VCAM-1 expression and monocyte adhesion in glioblastoma. | Q50894719 | ||
miR-124 radiosensitizes human glioma cells by targeting CDK4. | Q50913359 | ||
Natural killer T cells: drivers or passengers in preventing human disease? | Q51828144 | ||
Intrinsic tyrosine kinase activity is required for vascular endothelial growth factor receptor 2 ubiquitination, sorting and degradation in endothelial cells. | Q52855186 | ||
MAP kinase pathway gene copy alterations in NRAS/BRAF wild-type advanced melanoma. | Q54227390 | ||
miR-101 acts as a tumor suppressor by targeting Kruppel-like factor 6 in glioblastoma stem cells. | Q54321491 | ||
Notoginsenoside Ft1 promotes angiogenesis via HIF-1α mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathways. | Q54499021 | ||
Prognostic relevance of uPAR-del4/5 and TIMP-3 mRNA expression levels in breast cancer. | Q54633524 | ||
Glioblastoma multiforme metastasis outside the CNS: three case reports and possible mechanisms of escape. | Q55461135 | ||
[Relationship between miR-218 and CDK6 expression and their biological impact on glioma cell proliferation and apoptosis]. | Q55462716 | ||
The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling. | Q55463049 | ||
Role of connexin (gap junction) genes in cell growth control and carcinogenesis | Q60324708 | ||
[Changes in the functional status of the myocardium after left ventricular bypass] | Q71278768 | ||
Feedback circuitry between miR-218 repression and RTK activation in glioblastoma. | Q38878830 | ||
MicroRNA-320 inhibits cell proliferation in glioma by targeting E2F1. | Q38883624 | ||
miR-340 inhibits glioblastoma cell proliferation by suppressing CDK6, cyclin-D1 and cyclin-D2. | Q38893903 | ||
Prediction of clinical outcome in glioblastoma using a biologically relevant nine-microRNA signature | Q38929512 | ||
MiR-449a exerts tumor-suppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein | Q38930784 | ||
MiR-21 up-regulation mediates glioblastoma cancer stem cells apoptosis and proliferation by targeting FASLG. | Q38940603 | ||
MiR-15b targets cyclin D1 to regulate proliferation and apoptosis in glioma cells | Q38978071 | ||
Oncogenic miR-20a and miR-106a enhance the invasiveness of human glioma stem cells by directly targeting TIMP-2. | Q39007403 | ||
miR-7 inhibits glioblastoma growth by simultaneously interfering with the PI3K/ATK and Raf/MEK/ERK pathways | Q39017914 | ||
A lentivirus-mediated miR-23b sponge diminishes the malignant phenotype of glioma cells in vitro and in vivo | Q39026399 | ||
miR-221/222 confers radioresistance in glioblastoma cells through activating Akt independent of PTEN status | Q39051241 | ||
TGF-β-induced miR10a/b expression promotes human glioma cell migration by targeting PTEN. | Q39084923 | ||
Blockage of a miR-21/EGFR regulatory feedback loop augments anti-EGFR therapy in glioblastomas | Q39099065 | ||
MiRNA-329 targeting E2F1 inhibits cell proliferation in glioma cells | Q39124132 | ||
miR-125b inhibitor may enhance the invasion-prevention activity of temozolomide in glioblastoma stem cells by targeting PIAS3. | Q39125450 | ||
LRIG1 dictates the chemo-sensitivity of temozolomide (TMZ) in U251 glioblastoma cells via down-regulation of EGFR/topoisomerase-2/Bcl-2. | Q39126449 | ||
Celastrol inhibits TGF-β1-induced epithelial-mesenchymal transition by inhibiting Snail and regulating E-cadherin expression | Q39126470 | ||
Let-7b expression determines response to chemotherapy through the regulation of cyclin D1 in glioblastoma | Q39134240 | ||
microRNA-17 regulates the expression of ATG7 and modulates the autophagy process, improving the sensitivity to temozolomide and low-dose ionizing radiation treatments in human glioblastoma cells | Q39136340 | ||
Suppression of tumorigenicity by microRNA-138 through inhibition of EZH2-CDK4/6-pRb-E2F1 signal loop in glioblastoma multiforme | Q39147552 | ||
miR-181b modulates glioma cell sensitivity to temozolomide by targeting MEK1. | Q39156112 | ||
MiR-139 inhibits Mcl-1 expression and potentiates TMZ-induced apoptosis in glioma. | Q39172188 | ||
Stress response of glioblastoma cells mediated by miR-17-5p targeting PTEN and the passenger strand miR-17-3p targeting MDM2. | Q39198008 | ||
Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells | Q39198840 | ||
UBE2O negatively regulates TRAF6-mediated NF-κB activation by inhibiting TRAF6 polyubiquitination | Q39199690 | ||
miR-143 inhibits glycolysis and depletes stemness of glioblastoma stem-like cells | Q39200427 | ||
P53-induced microRNA-107 inhibits proliferation of glioma cells and down-regulates the expression of CDK6 and Notch-2. | Q39230616 | ||
Effect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells. | Q39281860 | ||
miR-92a is a critical regulator of the apoptosis pathway in glioblastoma with inverse expression of BCL2L11. | Q39296979 | ||
MiR-218 reverses high invasiveness of glioblastoma cells by targeting the oncogenic transcription factor LEF1. | Q39319071 | ||
MiR-410 regulates MET to influence the proliferation and invasion of glioma | Q39322020 | ||
The IL-10/STAT3 axis: Contributions to immune tolerance by thymus and peripherally derived regulatory T-cells | Q39385246 | ||
miR-221/222 is the regulator of Cx43 expression in human glioblastoma cells | Q39403463 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | glioblastoma | Q282142 |
P304 | page(s) | 452-474 | |
P577 | publication date | 2018-09-04 | |
P1433 | published in | NeuroMolecular Medicine | Q15716731 |
P1476 | title | Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma | |
P478 | volume | 20 |